Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nektar Therapeutics | ITH | Sep 19, 2024 | 1.12 | -2.61 |
NEL | D7G | Sep 19, 2024 | 0.48 | -0.87 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Sep 19, 2024 | 13.70 | +3.01 |
Nelly Group | CD20 | Sep 19, 2024 | 2.02 | +2.12 |
Nelnet, Inc. | NIJ | Sep 19, 2024 | 101.00 | 0.00 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Sep 19, 2024 | 16.60 | +0.61 |
Nemetschek SE | NEM | Sep 19, 2024 | 90.00 | +3.15 |
NENT Group B | NEB | Sep 19, 2024 | 0.06 | -4.73 |
Neo Performance Materials Inc | N14 | Sep 19, 2024 | 5.32 | +4.72 |
NEO-NEON | N2L | Sep 19, 2024 | 0.03 | -2.25 |
Neodecortech S.p.a. | FM2 | Sep 19, 2024 | 3.06 | -0.97 |
Neoen S.A. | N1N | Sep 19, 2024 | 38.66 | -0.16 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Sep 19, 2024 | 10.90 | 0.00 |
Neogen Corporation | NG2 | Sep 19, 2024 | 15.50 | +3.33 |
NeoGenomics, Inc. | NG9 | Sep 19, 2024 | 14.50 | 0.00 |
Neolife | 8JB | Sep 19, 2024 | 0.05 | -0.19 |
Neometals Ltd | 9R9 | Sep 19, 2024 | 0.05 | 0.00 |
NEOMETALS LTD SP.ADS/10 | 9R91 | Sep 19, 2024 | 0.43 | 0.00 |
NEON EQUITY NA O.N. | D77 | Sep 19, 2024 | 1.46 | 0.00 |
NeonMind Biosciences Inc | 6UF0 | Sep 19, 2024 | 0.00 | -50.00 |
Neosperience S.p.a | Y8E | Sep 19, 2024 | 1.11 | +1.37 |
NEOTECH METALS CORP. | V690 | Sep 19, 2024 | 0.09 | -19.47 |
Nephros | NPJP | Sep 19, 2024 | 1.60 | 0.00 |
Neptune Digital Assets Corp. | 1NW | Sep 19, 2024 | 0.15 | -2.88 |
Nerds On Site Inc | 3NS | Sep 19, 2024 | 0.02 | 0.00 |
Nerdwallet Inc | 6OI | Sep 19, 2024 | 11.70 | +1.74 |
NervGen Pharma Corp | 9UA | Sep 19, 2024 | 1.68 | +1.20 |
Neste | NEF | Sep 19, 2024 | 16.70 | +2.33 |
Neste OYJ American Depositary Receipts - Unsponsored | NEFA | Sep 19, 2024 | 8.00 | +0.63 |
Nestle SA | NESM | Sep 19, 2024 | 90.20 | -1.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.